April 16, 2026 · Form 4 insider transaction
Klencke Barbara bought 100,000 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.